Haemonetics Corporation, headquartered in Boston, MA, specializes in blood processing technologies that enhance the safety and efficiency of blood donation and transfusion. The company focuses on apheresis, thrombelastography, and plasma collection, providing innovative solutions for fluid flow measurement and continuous flow separation. With a commitment to advancing hemostasis testing and platelet washing, Haemonetics plays a crucial role in improving patient outcomes in healthcare settings globally.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

170 Patents

#20 in Boston, MA

#130 in Massachusetts

#2,350 in US

#4,869 in the World

Boston, MA, United States of America

Haemonetics Corporation

Forward Citations = 7,687

159 inventors:

Michael Ragusa (27 out of 27 patents)

Etienne Pagès (18 out of 18 patents)

Gary R Stacey (16 out of 17 patents)

4. Thomas D Headley (13 out of 36 patents)

5. Edward T Powers (12 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Haemonetics Corporation. Retrieved from https://idiyas.com/company/haemonetics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

57 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]